Abstract

Corticotropin releasing hormone (CRH) produced by the hypothalamus initiates the hypothalamic-pituitary-adrenal (HPA) axis, which regulates the body’s stress response. CRH levels typically are undetectable in human plasma, but during pregnancy the primate placenta synthesizes and releases large amounts of CRH into both maternal and fetal circulations. Notably, placental CRH synthesis increases in response to maternal stress signals. There is evidence that human fetal exposure to high concentrations of placental CRH is associated with behavioral consequences during infancy and into childhood, however the direct effects on of the peptide on the human brain are unknown. In this study, we used a rodent model to test the plausibility that CRH has direct effects on the developing cortex. Because chronic exposure to CRH reduces dendritic branching in hippocampal neurons, we tested the hypothesis that exposure to CRH would provoke impoverishment of dendritic trees in cortical neurons. This might be reflected in humans as cortical thinning. We grew developing cortical neurons in primary cultures in the presence of graded concentrations of CRH. We then employed Sholl analyses to measure dendritic branching and total dendritic length of treated cells. A seven-day exposure to increasing levels of CRH led to a significant, dose-dependent impoverishment of the branching of pyramidal-like cortical neurons. These results are consistent with the hypothesis that, rather than merely being a marker of prenatal stress, CRH directly decreases dendritic branching. Because dendrites comprise a large portion of cortical volume these findings might underlie reduced cortical thickness and could contribute to the behavioral consequences observed in children exposed to high levels of CRH in utero.

Highlights

  • Corticotropin-releasing hormone (CRH), a hypothalamic, 41-amino acid neuropeptide, has a major role in regulating pituitary–adrenal function and biological responses to stress [1,2,3,4,5,6]

  • The principal findings of this paper are (1) cortical neurons at the developmental stage roughly concordant with late human gestation are sensitive to CRH; (2) CRH influences dendritic branching in a dose-dependent manner

  • These effects are observed at CRH levels estimated to be present in the adult stressed brain [42]

Read more

Summary

Introduction

Corticotropin-releasing hormone (CRH), a hypothalamic, 41-amino acid neuropeptide, has a major role in regulating pituitary–adrenal function and biological responses to stress [1,2,3,4,5,6]. The expression of CRH in stress-sensitive hypothalamic neurons commences during fetal life [7,8,9], and the peptide contributes to the regulation of the response to stress throughout life. The peptide is released locally within the amygdala [14], hippocampus [15], and cortex [16], and contributes to the diverse effects of stress on brain functions, including memory and anxiety. During acute stress, CRH enhances memory through actions in the amygdala [14] and hippocampus [17]. Exposure to nanomolar levels of the peptide results in neuronal hyper-excitability [22], increased risk for seizures, and even neuronal death [23,24]

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call